BRIEF published on 10/08/2026 at 08:35, 4 days 6 hours ago GenSight Biologics and National Hospital Publish GS030 Trial Outcomes Gene Therapy GenSight Biologics Optogenetics Retinitis Pigmentosa GS030 PIONEER Trial
BRIEF published on 10/08/2026 at 08:35, 4 days 6 hours ago Publication of the results of the GS030 trial for retinitis pigmentosa Gene Therapy GenSight Biologics Optogenetics Retinitis Pigmentosa Trial Results
PRESS RELEASE published on 10/08/2026 at 08:30, 4 days 6 hours ago Inside Information / Other news releases GenSight Biologics and 15-20 National Hospital publish NEJM article on GS030 Phase 1/2 trial results for retinitis pigmentosa treatment, showcasing promising optogenetics approach GenSight Biologics Optogenetics 15-20 National Hospital NEJM Article GS030
BRIEF published on 10/08/2026 at 07:05, 4 days 8 hours ago GenSight Biologics Secures €1 Million Funding from Shareholders Shareholders Fundraising Financial Strategy GenSight Biologics Retinal Therapies
PRESS RELEASE published on 10/08/2026 at 07:00, 4 days 8 hours ago Inside Information / Other news releases GenSight Biologics successfully completes €1.0 million fundraising subscribed by existing shareholders. Proceeds to be used for operational activities and working capital requirements Shareholders Working Capital Fundraising Operational Activities GenSight Biologics
BRIEF published on 10/08/2026 at 01:06, 4 days 14 hours ago Financial position of GenSight Biologics as of September 30, 2026 Treasury Bridge Financing GenSight Biologics Phase III RECOVER Access Programs
BRIEF published on 09/30/2026 at 00:42, 12 days 14 hours ago GenSight Biologics Reports 2026 Interim Financial Results Funding Challenges GenSight Biologics Early Access Programs Financial Results 2026 Clinical Trials Update
PRESS RELEASE published on 09/30/2026 at 00:37, 12 days 14 hours ago Inside Information / News release on accounts, results GenSight Biologics reports interim financial results for the first half of 2026, including revenue of €(1.2) million, highlighting successful manufacturing technology transfer and progress in clinical studies Revenue Clinical Studies GenSight Biologics Interim Financial Results Manufacturing Technology Transfer
BRIEF published on 09/08/2026 at 07:35, 1 month 4 days ago GenSight Biologics: Review and Outlook as of September 2026 GenSight Biologics Gene Therapies REVISED STUDY LUMEVOQ® Manufacturing Access Programs
PRESS RELEASE published on 09/08/2026 at 07:30, 1 month 4 days ago Inside Information / Other news releases GenSight Biologics provides business updates on manufacturing, clinical activities, and financial status for September 2026, including progress on gene therapy treatments Financial Updates Manufacturing Business Updates Clinical Activities GenSight Biologics
Published on 10/12/2026 at 13:00, 2 hours 9 minutes ago U.S. Energy Secretary Chris Wright, EXIM Chairman John Jovanovic, Nebraska Governor Jim Pillen, Senators Deb Fischer and Pete Ricketts, and Congressman Adrian Smith to Visit NioCorp's Critical Minerals Mine Site
Published on 10/10/2026 at 04:45, 2 days 10 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 2 days 13 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 2 days 13 hours ago Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 2 days 16 hours ago Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/12/2026 at 14:35, 33 minutes ago Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.03 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $16.2 Billion
Published on 10/12/2026 at 14:15, 53 minutes ago Schaeffler completes earnings improvement program with about 1,800 additional partial retirement agreements
Published on 10/12/2026 at 14:00, 1 hour 8 minutes ago Lonza Expands Dual-Payload ADC Technology Offering Through Exclusive Access to Qurient’s CDK7 Inhibitors
Published on 10/12/2026 at 13:50, 1 hour 18 minutes ago Fibank and Bitpanda Forge Strategic Partnership to Launch Integrated Crypto Asset Access via My Fibank Mobile App
Published on 10/12/2026 at 13:43, 1 hour 25 minutes ago EQS-Adhoc: Semperit AG Holding raises earnings forecast for full year 2026
Published on 10/12/2026 at 14:15, 53 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from October 5 to October 9, 2026
Published on 10/09/2026 at 19:27, 2 days 19 hours ago Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/08/2026 at 18:30, 3 days 20 hours ago Cegedim: Release of its 2026 Interim Financial Report
Published on 10/08/2026 at 18:00, 3 days 21 hours ago Launch of LINK, the next generation of THIN: Clinityx’s first European Health Data Warehouse, approved by the French Data Protection Authority for 10 years
Published on 10/08/2026 at 17:45, 3 days 21 hours ago Carrefour announces a real estate sale and leaseback transaction involving 35 stores in France and Spain
